Evaluating the drop test method in measuring colistin susceptibility of Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa

References

1. Aghapour Z, Gholizadeh P, Ganbarov K, Bialvaei AZ, Mahmood SS et al. Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect Drug Resist 2019; 12:965–975 [View Article] [PubMed]
   [Google Scholar]
2. Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of Infections Due to MDR Gram-Negative Bacteria. Front Med 2019; 6:dx [View Article]
   [Google Scholar]
3. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D et al. Infectious Diseases Society of America Guidance on the treatment of AmpC β-Lactamase-producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin Infect Dis 2022; 74:2089–2114 [View Article]
   [Google Scholar]
4. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D et al. Infectious diseases society of america guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR- P. aeruginosa). Clin Infect Dis 2021; 72:e169-183 [View Article]
   [Google Scholar]
5. El-Sayed Ahmed MAE-G, Zhong L-L, Shen C, Yang Y, Doi Y et al. Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). Emerg Microbes Infect 2020; 9:868–885 [View Article] [PubMed]
   [Google Scholar]
6. EUCAST Recommendations for MIC determination of colistin (polymyxin E) as recommended by the joint CLSI-EUCAST polymyxin Breakpoints Working Group; 2016 http://www.eucast.org
7. Tsuji BT, Pogue JM, Zavascki AP, Paul M, Daikos GL et al. International consensus guidelines for the optimal279 use of the polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP),280 European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious281 Diseases Society of America (IDSA), International Society for Anti-infective282 Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of283 Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 2019; 39:10–39 [View Article]
   [Google Scholar]
8. CLSI Performance standards for antimicrobial susceptibility testing, 28th edn,CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018
   [Google Scholar]
9. Matuschek E, Åhman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect 2018; 24:865–870 [View Article] [PubMed]
   [Google Scholar]
10. International Organization for Standardization Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices—part 1: broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases ISO 20776-1:2019; 2019
11. Osei Sekyere J, Sephofane AK, Mbelle NM. Comparative Evaluation of CHROMagar COL-APSE, MicroScan Walkaway, ComASP Colistin, and Colistin MAC Test in Detecting Colistin-resistant Gram-Negative Bacteria. Sci Rep 2020; 10:1–13 [View Article]
    [Google Scholar]
12. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. version 12.0; 2022 http://www.eucast.org
13. European Centre for Disease Prevention and Control External Quality Assessment of Laboratory Performance: European Antimicrobial Resistance Surveillance Network (EARSNet); 2017
14. Jouy E, Haenni M, Le Devendec L, Le Roux A, Châtre P et al. Improvement in routine detection of colistin resistance in E. coli isolated in veterinary diagnostic laboratories. J Microbiol Methods 2017; 132:125–127 [View Article] [PubMed]
    [Google Scholar]
15. Pasteran F, Danze D, Menocal A, Cabrera C, Castillo I et al. Simple phenotypic tests to improve accuracy in screening chromosomal and plasmid-mediated colistin resistance in gram-negative bacilli. J Clin Microbiol 2020; 59:e01701-20 [View Article]
    [Google Scholar]
16. Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T et al. CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol 2018; 56:e01934-17 [View Article]
    [Google Scholar]
17. International Organization for Standardization Clinical laboratory testing and in vitro diagnostic test systems—susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices—part 2: evaluation of performance of antimicrobial susceptibility test devices ISO 20776-2:2021; 2021
18. Food and Drug Administration Guidance for Industry and FDA. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; 2009
19. Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P et al. ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. Clin Microbiol Infect 2019; 25:807–817 [View Article] [PubMed]
    [Google Scholar]
20. Kar P, Behera B, Mohanty S, Jena J, Mahapatra A. Detection of Colistin Resistance in Carbapenem Resistant Enterobacteriaceae by Reference Broth Microdilution and Comparative Evaluation of Three Other Methods. J Lab Physicians 2021; 13:263–269 [View Article] [PubMed]
    [Google Scholar]